TFS Capital’s Traws Pharma TRAW Stock Holding History

TFS Capital’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-1	Closed	-$324K	–	1235
2014 Q2	$324K	Buy	+1	New	+$295K	0.03%	804
2013 Q4	–	Hold	0	–	-$683K	–	1664
2013 Q3	–	Hold	0	–	–	–	731

Other funds holding TRAW

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

TFS Capital's TRAW Position: Q3 2014 in Review

TFS Capital sold out of Traws Pharma (TRAW) in Q3 2014, closing a stake of 1 share — an estimated $324K sold.

TFS Capital first reported a position in TRAW in Q2 2014 and held it in 1 quarter. The position peaked at $324K in Q2 2014. 12 funds tracked by Wall St. Rank hold TRAW as of Q3 2014.

TFS Capital reported no remaining Traws Pharma position as of Q3 2014 after selling out during the quarter.
TFS Capital sold 1 Traws Pharma share in Q3 2014, an estimated $324K.
TFS Capital first reported a position in Traws Pharma in Q2 2014 and held it in 1 quarter.
TFS Capital's Traws Pharma position peaked at $324K in Q2 2014.
12 funds tracked by Wall St. Rank held Traws Pharma as of Q3 2014.

Based on TFS Capital's 13F filing for Q3 2014, filed 6 Nov 2014.